Cargando…
Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure
Background: Clozapine is a key antipsychotic drug for treatment-resistant schizophrenia but exhibits highly variable pharmacokinetics and a propensity for serious adverse effects. Currently, these challenges are addressed using therapeutic drug monitoring (TDM). This study primarily sought to (i) ve...
Autores principales: | Wills, Kenneth H., Behan, Stephen J., Nance, Michael J., Dawson, Jessica L., Polasek, Thomas M., Hopkins, Ashley M., van Dyk, Madelé, Rowland, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779032/ https://www.ncbi.nlm.nih.gov/pubmed/35056943 http://dx.doi.org/10.3390/pharmaceutics14010047 |
Ejemplares similares
-
Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate
por: van Dyk, Madelé, et al.
Publicado: (2019) -
Physiologically-based pharmacokinetic model for clozapine in Korean patients with schizophrenia
por: Lee, Joomi, et al.
Publicado: (2021) -
The Effect of Liver and Kidney Disease on the Pharmacokinetics of Clozapine and Sildenafil: A Physiologically Based Pharmacokinetic Modeling
por: Ghoneim, Amira M, et al.
Publicado: (2020) -
The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption
por: Levitt, David G
Publicado: (2003) -
Optimized Cocktail Phenotyping Study Protocol Using Physiological Based Pharmacokinetic Modeling and In silico Assessment of Metabolic Drug–Drug Interactions Involving Modafinil
por: Rowland, Angela, et al.
Publicado: (2016)